• ≥18 years of age at the time of signing informed consent.

• Stage 0-3 hormone-receptor positive breast cancer confirmed at MSKCC

• Able to complete study questionnaires in English or Spanish

• Breast cancer patients must have completed chemotherapy or radiation therapy (and can be on maintenance therapy)

• Currently on an aromatase inhibitor or tamoxifen

• Currently have no clinical evidence of disease

• Reporting being bothered by vaginal symptoms of estrogen deprivation (i.e., vaginal dryness, dyspareunia, or discomfort \[pain with intercourse or examination\])

• A total score of 4 or greater in VAS

• Without history of other cancers (excluding non-melanoma skin cancer)

• Must sign an informed consent indicating that the participant understands the purpose of, and procedures required for the study and is willing to participate in the study